Related Experiment Videos
Salicylate kinetics in old age
Clinical Pharmacology and Therapeutics
|July 1, 1985
Summary
Salicylate drug clearance remains similar in most older adults, though some show slower elimination due to factors like reduced albumin levels. This study examined salicylate pharmacokinetics in aging individuals.
Area of Science:
- Pharmacology
- Gerontology
- Clinical Chemistry
Background:
- Aging can alter drug pharmacokinetics, affecting drug efficacy and safety.
- Salicylate is commonly used, and understanding its behavior in older populations is crucial.
Purpose of the Study:
- To investigate the relationship between age and salicylate pharmacokinetics.
- To identify factors influencing salicylate clearance and protein binding in elderly subjects.
Main Methods:
- Administered single oral doses of sodium salicylate to 28 subjects aged 25-92 years.
- Measured serum salicylate levels (total and unbound) and calculated AUCinfinity.
- Assessed correlations with age, sex, albumin, creatinine, and other clinical markers.
Main Results:
- Serum AUCinfinity of total salicylate did not correlate with age.
- A weak positive correlation was observed between unbound salicylate AUCinfinity and age.
- Decreased serum protein binding of salicylate, primarily due to lower albumin, was associated with increasing age.
Conclusions:
- While total salicylate levels are not age-dependent, unbound salicylate exposure may increase with age.
- Reduced serum albumin in older adults contributes to decreased salicylate protein binding.
- Slower salicylate elimination in some elderly individuals may be linked to reduced albumin and bedridden status.